Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4): 12 New Employees Receive Restricted Stock Units for a Total of 94,000 Shares

Arcutis Biotherapeutics has granted 94,000 restricted stock units to 12 newly hired employees under the Arcutis Biotherapeutics, Inc. 2022 Inducement Plan. The restricted stock units vest over four years, with 25% vesting annually, subject to continuous employment with Arcutis. The awards were approved by the Compensation Committee of Arcutis' Board of Directors and granted as an inducement material to the new employees entering into employment with Arcutis.